Literature DB >> 30220787

Neurobiology and Clinical Manifestations of Methamphetamine Neurotoxicity.

Anna Moszczynska1.   

Abstract

Entities:  

Year:  2016        PMID： 30220787      PMCID： PMC6135110     

Source DB:  PubMed          Journal:  Psychiatr Times        ISSN： 0893-2905


× No keyword cloud information.
  17 in total

Review 1.  Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Jeb S Perkins; Mario A González
Journal:  Hum Psychopharmacol       Date:  2009-01       Impact factor: 1.672

2.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats.

Authors:  Bryan Killinger; Mrudang Shah; Anna Moszczynska
Journal:  J Neurochem       Date:  2013-12-03       Impact factor: 5.372

4.  Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine.

Authors:  Paul S Fitzmaurice; Junchao Tong; Mehrdad Yazdanpanah; Peter P Liu; Kathryn S Kalasinsky; Stephen J Kish
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

Review 5.  Methamphetamine - Effects on Human Performance and Behavior.

Authors:  B K Logan
Journal:  Forensic Sci Rev       Date:  2002-02

Review 6.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

Authors:  Linda Chang; Daniel Alicata; Thomas Ernst; Nora Volkow
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

Review 7.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

8.  Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic.

Authors:  Antonio Urbina; Kristina Jones
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

9.  Brain antioxidant systems in human methamphetamine users.

Authors:  Anna Mirecki; Paul Fitzmaurice; Lee Ang; Kathryn S Kalasinsky; Frank J Peretti; Sally S Aiken; Dennis J Wickham; Allan Sherwin; José N Nobrega; Henry J Forman; Stephen J Kish
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

10.  Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine.

Authors:  Brian M Ross; Anna Moszczynska; Frank J Peretti; Vernard Adams; Gregory A Schmunk; Kathryn S Kalasinsky; Lee Ang; Nikolaos Mamalias; Sylvie D Turenne; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2002-06-01       Impact factor: 4.492
View more
  3 in total

1.  Injuries and poisonings associated with methamphetamine use: sentinel surveillance, the electronic Canadian Hospitals Injury Reporting and Prevention Program (eCHIRPP), 2011-2019.

Authors:  Steven R McFaull; André Champagne; Wendy Thompson; Felix Bang
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-04       Impact factor: 3.240

Review 2.  Oxytocin and Addiction: Potential Glutamatergic Mechanisms.

Authors:  Megana Sundar; Devon Patel; Zachary Young; Kah-Chung Leong
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

3.  Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study.

Authors:  Lukas Andreas Basedow; Sören Kuitunen-Paul; Melina Felicitas Wiedmann; Stefan Ehrlich; Veit Roessner; Yulia Golub
Journal:  BMC Psychiatry       Date:  2021-03-25       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.